30944 Federal Register / Vol. 83, No. 127 / Monday, July 2, 2018 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Statement of Organization, Functions, 

and Delegations of Authority 

Part M of the Substance Abuse and 

Mental Health Services Administration 

(SAMHSA) Statement of Organization, 

Functions, and Delegations of Authority 

for the Department of Health and 

Human Services (DHHS) is amended to 

reflect new functional statements for the 

Office of the Assistant Secretary for 

Mental Health and Substance Use and 

the Center for Behavioral Health 

Statistics and Quality. In addition this 

notice establishes the new National 

Mental Health and Substance Use Policy 

Laboratory (NMHSUPL). This 

reorganization is to ensure compliance 

with the requirements set forth in the 

21st Century Cures Act, and to better 

align the agency in maximizing the 

talent and resources available to 

improve the efficiency of SAMHSA 

programs. 

Section M.20, Functions is amended 

as follows: 

Establishing the Office of the 

Assistant Secretary for Mental Health 

and Substance Use (OAS) and 

abolishing the Immediate Office of the 

Administrator. Realigning the 

President’s Emergency Plan for AIDS 

Relief Activities Branch from the Center 

for Substance Abuse Treatment to the 

OAS. Realigning the Office of Tribal 

Affairs and Policy, the Office of Indian 

Alcohol and Substance Abuse, the 

Office of the Chief Medical Officer, and 

the Executive Correspondence Branch, 

from the Office of Policy, Planning, and 

Innovation (OPPI) to the OAS. 

Renaming the Office of Behavioral 

Health Equity to the Office of Behavioral 

Health Equity and Justice-Involved and 

renaming the Division of Regional and 

National Policy Liaison to the Office of 

Intergovernmental and External Affairs 

and realigning both from OPPI to the 

OAS. Establishing the National Mental 

Health and Substance Use Policy 

Laboratory and transferring to it the 

functions of OPPI. Abolishing the 

Division of Policy Coordination and the 

Division of Policy Innovation and Policy 

Analysis Branch from OPPI. Codifying 

the existing Center for Behavioral 

Health Statistics and Quality (CBHSQ) 

and renaming CBHSQ’s Division of 

Evaluation, Analysis, and Quality to the 

Office of Evaluation. The Office of 

Communication remains an integral part 

of the OAS and was not impacted by 

this reorganization. The functional 

statement for each office is changed to 

read as follows: 

Office of the Assistant Secretary (MA) 

The Office of the Assistant Secretary 

(OAS): (1) Maintains a system to 

disseminate research findings and 

evidence-based practices to service 

providers to improve treatment and 

prevention services and incorporate 

these findings into SAMHSA programs; 

(2) ensures that grants are subject to 

performance and outcome evaluations 

and that center directors consistently 

document the grant process and conduct 

ongoing oversight of grantees; (3) 

consults with stakeholders to improve 

community-based and other mental 

health services, including adults with a 

serious mental illness (SMI), and 

children with a serious emotional 

disturbance (SED); (4) collaborates with 

other federal departments, including the 

Departments of Defense (DOD), Veterans 

Affairs (VA), Housing and Urban 

Development (HUD), and Labor (DOL) 

to improve care for veterans and service 

members, and support programs to 

address chronic homelessness; and (5) 

works with stakeholders to improve the 

recruitment and retention of mental 

health and substance use disorder 

professionals. In addition, the OAS 

provides leadership in the development 

of agency policies and programs, and 

maintains a close working relationship 

and coordination with Congress, other 

operating and staff divisions within the 

Department of Health and Human 

Services, and external Federal and 

private sector entities. 

The OAS consists of the Office of 

Communications, Office of 

Intergovernmental and External Affairs, 

the Office of Behavioral Health Equity 

and Justice-Involved, the Office of 

Tribal Affairs and Policy/Office of 

Indian Alcohol and Substance Abuse, 

and the Office of the Chief Medical 

Officer. 

Office of Communications (MAB) 

Provides leadership in the 

development of SAMHSA’s priorities, 

strategies, and practices for effective 

communications to targeted public 

audiences, including relations with the 

media; and serves as a focal point for 

communications activities as follows: 

(1) Coordinates agency communications 

activities; (2) plans public events, 

including press conferences, speeches, 

and site visits for the Administrator, 

other SAMHSA officials, and DHHS 

representatives; (3) publishes SAMHSA 

brochures, fact sheets, and quarterly 

issues of SAMHSA News; (4) 

coordinates electronic dissemination of 

information, within the Agency and 

through the internet and World-Wide 

Web; (5) develops communications 

channels and targets media placements; 

(6) develops and disseminates news 

releases and coordinates media contacts 

with Agency representatives; (7) 

provides editorial and policy review of 

all Agency publications; (8) fulfills 

public affairs requirements of DHHS; (9) 

provides Agency contributions to the 

DHHS forecast report on significant 

activities; and (10) manages the Agency 

conference exhibit program. 

Office of Intergovernmental and 

External Affairs (MAC) 

The Office of Intergovernmental and 

External Affairs (OIEA) serves as the 

central point for providing leadership 

and coordination in establishing and 

maintaining a collaborative effort 

between SAMHSA, other government 

agencies, and service providers in order 

to improve behavioral health outcomes. 

The Office is SAMHSA’s lead for 

institutional and intergovernmental 

communication and coordination. As 

such, the Office: (1) Ensures that critical 

information from the field is 

incorporated into all policy activities 

and shared broadly across SAMHSA to 

support program development and 

implementation; (2) establishes and 

sustains relationships between 

SAMHSA and key stakeholders in other 

government agencies and institutions; 

(3) ensures that SAMHSA’s policies are 

effectively communicated to Regional 

and National stakeholders; and, (4) 

meets routinely with staff from Centers 

and Offices to discuss program policy 

issues, seek input, and review progress. 

Office of Behavioral Health Equity and 

Justice-Involved (MACA) 

The Office of Behavioral Health 

Equity and the Justice-Involved 

(OBHEJI) coordinates agency efforts to 

ensure that racial and ethnic minority, 

underserved, and criminal justiceinvolved populations have equitable 

access to high quality behavioral health 

care. Functions of the office include: (1) 

Strengthening SAMHSA’s capacity, 

through its grant programs and technical 

assistance efforts, to address the 

behavioral health needs of minority, 

underserved and justice involved 

populations; (2) enhancing 

measurement and data strategies to 

identify, assess and respond to the 

behavioral health challenges for these 

populations; (3) promoting policy 

initiatives that strengthen SAMHSA’s 

programs and the broader field in 

improving the behavioral health of the 

underserved and the justice-involved; 

and, (4) expanding the behavioral health 


daltland on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 83, No. 127 / Monday, July 2, 2018 / Notices 30945 

workforce capacity to improve outreach, 

engagement and quality of care. 

Office of Tribal Affairs and Policy/ 

Office of Indian Alcohol and Substance 

Abuse (MACB) 

The Office of Tribal Affairs and Policy 

(OTAP)/Office of Indian Alcohol and 

Substance Abuse (OIASA) coordinates 

federal partners and provides tribes 

with technical assistance and resources 

to develop and enhance prevention and 

treatment programs for substance use 

disorders, including the misuse of 

alcohol. The Office serves as the 

agency’s primary point of contact for 

tribal governments, tribal organizations, 

and federal agencies on behavioral 

health issues that impact tribal 

communities. 

OTAP/OIASA is charged with 

aligning, leveraging, and coordinating 

federal agencies and departments in 

carrying out SAMHSA’s responsibilities 

delineated in the Tribal Law and Order 

Act (TLOA). This effort is overseen 

through the Indian Alcohol and 

Substance Abuse (IASA) 

Interdepartmental Coordinating 

Committee, which is comprised of more 

than 60 members representing a range of 

federal agencies and departments. 

PEPFAR Activities Branch (MACC) 

The President’s Emergency Plan for 

AIDS Relief (PEPFAR) Activities 

Branch: (1) Provides leadership and 

direction to activities, under the 

PEPFAR mission, that impact the global 

HIV epidemic through the delivery of 

substance abuse treatment as part of 

HIV/AIDS prevention, care, and 

treatment; (2) serves as the point of 

contact (POC) for all SAMHSA PEPFAR 

operational activities and provides 

leadership and direction to technical, 

budget and programmatic aspects of the 

SAMHSA PEPFAR program; (3) works 

in collaboration with other agency’s 

staff to guide policy development and 

innovation related to HIV and hepatitis 

within the context of a broader 

international agenda, including work 

with other SAMHSA Centers to identify 

additional behavioral health evidence 

based practices and initiatives that are 

relevant to SAMHSA’s role in PEPFAR; 

(4) serves as the POC for both the Office 

of Global Affairs in HHS and the Office 

of the Global AIDS Coordinator and 

Health Diplomacy (S/GAC) in the State 

Department on all SAMHSA PEPFAR 

related activities and coordinates all 

matters of PEPFAR policy; and (5) 

oversees and coordinates 

responsibilities for PEPFAR within 

SAMHSA, including (a) SAMHSA 

PEPFAR operational activities to 

include budget, programmatic activities, 

as well as, new initiatives and activities 

developed at the Office of the Global 

AIDS Coordinator and Health 

Diplomacy (S/GAC); (b) SAMHSA 

PEPFAR data activities and reporting to 

the Interagency Collaborative for 

Program Improvement (ICPI); (c) 

SAMHSA related PEPFAR Technical 

Working Group (TWG) activities and 

assignments; (d) SAMHSA headquarters 

technical assistance (TDYs) on 

substance abuse treatment and HIV 

prevention, care and treatment; and (e) 

SAMHSA participation in PEPFAR 

country reviews and new and evolving 

PEPFAR activities, including policy 

development. 

Executive Correspondence and Support 

Branch (MACD) 

The Executive Correspondence and 

Support Branch: (1) Receives, analyzes, 

assigns, distributes and tracks executive 

correspondence and maintains files; (2) 

ensuring responsiveness, quality and 

timeliness of executive correspondence; 

(3) issues guidance and establishes 

administrative processes to ensure that 

executive correspondence complies 

with all DHHS requirements and reflects 

positively on the reputation of 

SAMHSA; and, (4) responds to Freedom 

of Information Act requests. 

Office of the Chief Medical Officer 

(MAD) 

The Office of the Chief Medical 

Officer (OCMO) provides assistance to 

the Assistant Secretary in evaluating 

and organizing programs within the 

Agency, and to promote evidence-based 

and promising best practices 

emphasizing clinical focus. The OCMO 

has in-depth experience providing 

mental health care or substance use 

disorder treatment services. 

Furthermore, the OCMO coordinates 

with the Assistant Secretary for 

Planning and Evaluation (ASPE) to 

assess the use of performance metrics to 

evaluate SAMHSA programs, and to 

coordinate with the Assistant Secretary 

to ensure consistent utilization of 

appropriate performance metrics and 

evaluation designs. 

National Mental Health and Substance 

Use Policy Laboratory (MD) 

The National Mental Health 

Substance Use and Policy Laboratory 

(NMHSUPL) promotes evidence-based 

practices and service delivery models 

through evaluating models that would 

benefit from further development and 

through expanding, replicating, or 

scaling evidence-based programs across 

a wider area. The NMHSUPL: (1) 

Identifies, coordinates, and facilitates 

the implementation of policy changes 

likely to have a significant effect on 

mental health, mental illness (especially 

severe mental illnesses such as 

schizophrenia and schizoaffective 

disorders), recovery supports, and the 

prevention and treatment of substance 

use disorder services; (2) works with the 

Center for Behavioral Health Statistics 

and Quality (CBHSQ) to collect 

information from grantees under 

programs operated by the 

Administration in order to evaluate and 

disseminate information on evidencebased practices, including culturally 

and linguistically appropriate services, 

as appropriate, and service delivery 

models; and (3) carry out other activities 

as deemed necessary to continue to 

encourage innovation and disseminate 

evidence-based programs and practices. 

Center for Behavioral Health Statistics 

and Quality (MC) 

The Center for Behavioral Health 

Statistics and Quality: (1) Coordinates 

the Assistant Secretary for Mental 

Health and Substance Use’s integrated 

data strategy, which includes collecting 

data each year on the national incidence 

and prevalence of the various forms of 

mental illness and substance abuse; (2) 

provides statistical and analytical 

support for activities of the Assistant 

Secretary for Mental Health and 

Substance Use, and the Secretary of 

DHHS; (3) recommends a core set of 

performance metrics to evaluate 

activities supported by the 

Administration; (4) coordinates with the 

Assistant Secretary for Mental Health 

and Substance Use, the Assistant 

Secretary for Planning and Evaluation, 

and the Substance Abuse and Mental 

Health Services Administration 

(SAMHSA) Chief Medical Officer, as 

appropriate, to improve the quality of 

services provided by programs and the 

evaluation of activities carried out by 

the Administration; (5) works with the 

National Mental Health and Substance 

Use Policy Laboratory to collect, as 

appropriate, information from grantees 

under programs in order to evaluate and 

disseminate information on evidencebased practices, including culturally 

and linguistically appropriate services, 

as appropriate, and service delivery 

models; (6) improves access to reliable 

and valid information on evidencebased programs and practices, including 

information on the strength of evidence 

associated with such programs and 

practices, related to mental and 

substance use disorders; (7) compiles, 

analyzes, and disseminates behavioral 

health information for statistical 

purposes. 


daltland on DSKBBV9HB2PROD with NOTICES
30946 Federal Register / Vol. 83, No. 127 / Monday, July 2, 2018 / Notices 

Office of the Director (MC1) 

The Office of the Director: (1) Plans, 

directs, administers, coordinates, and 

evaluates the integrated data strategy of 

the Center; (2) ensures that data 

collection, analytic activities, 

dissemination activities, and evaluation 

efforts are consistent with the mission 

and priorities of the Department and the 

Agency; (3) directs the Center’s health 

systems statistical programs and 

evaluations; (4) provides management 

and administration for the Center; (5) 

serves as Agency primary liaison to the 

Office of the Secretary, the Office of 

National Drug Control Policy, and other 

Federal agencies; to State and local 

government agencies; and to nongovernmental organizations and 

institutions on matters related to the 

collection and analysis of data on 

substance use and mental health issues; 

and (6) oversees the process for internal 

clearance, publishing, and 

dissemination of statistical studies, 

reports, and evaluations produced by 

CBHSQ. 

Office of Program Analysis and 

Coordination (MCA) 

The Office of Program Analysis and 

Coordination supports the Center’s 

implementation of programs and 

policies by providing guidance in the 

administration, analysis, planning, and 

coordination of the Center’s programs, 

consistent with agency priorities. 

Specifically the Office: (1) Manages the 

Center’s participation in the agency’s 

policy, planning, budget formulation 

and execution, program development 

and clearance, and internal and external 

requests, including strategic planning, 

identification of program priorities, and 

other agency-wide and departmental 

planning activities; (2) Provides support 

for the Center Director, including 

coordination of staff development 

activities, analysis of the impact of 

proposed legislation and rule-making, 

and supporting administrative 

functions, including human resourcerelated actions; and (3) coordinates 

release of survey data information 

through electronic reports and web 

based media in conjunction with Office 

of Communication. 

Division of Surveillance and Data 

Collection (MCB) 

The Division is responsible for 

developing, conducting, and improving 

surveys carried out by CBHSQ 

according to statute. Specifically the 

Division: (1) Plans, develops, and 

manages the national surveys of the 

general population, treatment providers, 

and patients focused on behavioral 

health disorders, adverse consequences, 

and treatment utilization and 

availability; (2) consistent with the 

CBHSQ publications plan, makes 

CBHSQ data available to the general 

public, policymakers at the Federal, 

state, and local government levels, and 

researchers through annual reports for 

agency, peer- reviewed sources, 

publications, and customized data files 

(public and restricted-use) in 

accordance with confidentiality statutes 

and regulations and OMB guidance and 

with Federal partners, as appropriate; 

(3) carries out methodological studies to 

assess and improve data collection 

methods and data quality and 

determines the comparability of data 

from SAMHSA surveys with those of 

other surveys conducted on behavioral 

health disorders; (4) responds to data 

inquiries and provides technical 

assistance to SAMHSA, other Federal 

agencies, state, and local governments, 

private organizations, researchers, and 

the public on the findings and 

appropriate interpretation of the data 

from CBHSQ surveys, as well as surveys 

sponsored by other organizations; (6) 

serves as a source of expertise for 

SAMHSA and the Department on survey 

methods, sampling design, statistics, 

analytical techniques, and participates 

in interagency workgroups to promote 

information-sharing and collaboration 

on statistical issues across agencies; and 

(7) manages statistical and analytical 

support team that analyzes and 

disseminates CBHSQ data. 

Population Surveys Branch (MCBA) 

The Population Surveys Branch plans, 

develops, and manages the National 

Survey on Drug Use and Health 

(NSDUH). Specifically the Branch: (1) 

According to statute, provides annual 

national estimates, as well as periodic 

state, sub-state, and metropolitan area 

estimates on the incidence, prevalence, 

correlates, and consequences of illicit 

drug use, alcohol and tobacco use, and 

mental health disorders and related 

treatment in the general population; (2) 

keeps abreast of current advances in 

survey design techniques and emerging 

data needs and research findings, and 

updates the survey design and analysis 

plans to meet those needs; and develops 

and implements new questionnaires and 

sampling, data collection, estimation, 

and analysis methods reflecting these 

needs for surveys; (3) manages the 

NSDUH data collection by reviewing the 

data collection materials, observing data 

collection, observing field interviewer 

training, tracking response rates, and 

resolving data quality problems; (4) 

evaluates methods used in population 

surveys and their impact on data 

quality, including comparing CBHSQ 

data with other existing data to help 

guide interpretation and promote 

appropriate uses of data; (5) manages 

the survey contract to ensure the 

reliability and validity of the data and 

(6) maintains partnerships with other 

organizations collecting and analyzing 

data on behavioral health disorders in 

support of agency’s mission. 

Treatment Services Branch (MCBB) 

The Treatment Services Branch plans, 

develops, and manages national surveys 

of mental health and substance use 

treatment service facilities and client 

level data collections related to the 

nation’s behavioral health treatment 

systems according to statute. These data 

collections include the National Survey 

of Substance Abuse Treatment Services 

(N–SSATS), the National Mental Health 

Services Survey (N–MHSS), the 

Treatment Episode Data Set (TEDS), the 

Mental Health Client-Level Data (MH– 

CLD) system, the SAMHSA Emergency 

Department Surveillance System 

(SEDSS) and other studies of the 

behavioral health treatment system. 

Specifically the Branch: (1) Provides 

annual national census data, as well as 

State, and metropolitan area data on the 

number, location, services provided, 

operational characteristics, and 

utilization of mental health and 

substance use treatment facilities; and 

provides client-level data on the 

characteristics of persons admitted to 

behavioral health treatment and their 

status post-admission and at discharge; 

(2) according to statute, manages and 

directs the collection of survey data 

used to develop and maintain a webbased treatment service Locator for 

behavioral health disorders, and 

conducts periodic testing and analyses 

to improve the accessibility and utility 

of the Locator and collaborates with the 

SAMHSA Office of Communication, as 

appropriate, in usability studies; (3) 

manages the associated survey contracts 

to ensure the reliability and validity of 

the data; (4) maintains the quality and 

relevance of the data through 

partnership with state behavioral health 

agencies, and (5) coordinates 

partnership efforts with the Center for 

Disease Control, National Center for 

Health Statistics (NCHS) related to the 

collection of behavioral health 

emergency department data for SEDSS 

through the National Ambulatory 

Medical Care Survey (NHCS). 

Office of Evaluation (MCC) 

The Office of Evaluation is 

responsible for providing centralized 

planning and management of program 

evaluation across SAMHSA in 


daltland on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 83, No. 127 / Monday, July 2, 2018 / Notices 30947 

partnership with program originating 

Centers, providing oversight and 

management of agency quality 

improvement and performance 

management activities and for 

advancing agency goals and objectives 

related to program evaluation, 

performance measurement, and quality 

improvement. Specifically, the Office: 

(1) Develops evaluation language for 

Request for Proposals (RFPs), Request 

for Applications (RFAs), and other 

funding announcements to ensure a 

clear statement of evaluation 

expectations in the announcements; (2) 

develops and implements standard 

measures for evaluating program 

performance and improvement of 

services; (3) manages the design of 

SAMHSA program evaluations in 

collaboration with the relevant 

Center(s); (4) monitors evaluation 

contracts to ensure implementation of 

planned evaluation and provides early 

feedback regarding program start-up for 

use in agency decision-making; (5) 

works collaboratively with the National 

Mental Health and Substance Use Policy 

Laboratory to provide support for 

SAMHSA evaluations; (6) oversees the 

identification of a set of performance 

indicators to monitor each SAMHSA 

program in collaboration with program 

staff and the development of periodic 

evaluation reports for use in agency 

planning, program change, and 

reporting to departmental and external 

organizations; (7) provides 

collaboration, guidance, and systematic 

feedback on SAMHSA’s programmatic 

investments to support the agency’s 

policy and program decisions; (8) 

analyzes and disseminates evaluation 

related data and reports in support of 

Secretarial and Assistant Secretarial 

initiatives and develops evaluation and 

performance related reports in response 

to internal and external requests; (9) 

provides oversight of the agency’s 

quality improvement efforts, including 

the collection, analysis, and reporting of 

performance measurement and quality 

monitoring and improvement data; (10) 

provides oversight and management of 

SAMHSA’s Performance Accountability 

and Reporting System (SPARS) which 

serves as a mechanism for the collection 

of performance data from agency 

grantees; (11) responds to agency and 

departmental requests for performance 

measurement data and information; and 

conducts a range of analytic and support 

activities to promote the use of 

performance data and information in the 

monitoring and management of agency 

programs and initiatives; and (12) 

maintains the posting, on the internet, 

of information on evidence-based 

programs and practices that have been 

reviewed by the Assistant Secretary for 

Mental Health and Substance Use. 

Delegation of Authority 

All delegations and re-delegations of 

authority made to SAMHSA officials 

that were in effect immediately prior to 

this reorganization, and that are 

consistent with this reorganization, 

shall continue in effect pending further 

re-delegation. 

Dated: June 25, 2018. 

Alex M. Azar II, 

Secretary. 

[FR Doc. 2018–14165 Filed 6–29–18; 8:45 am] 

BILLING CODE 4160–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Current List of HHS-Certified 

Laboratories and Instrumented Initial 

Testing Facilities Which Meet Minimum 

Standards To Engage in Urine Drug 

Testing for Federal Agencies 

AGENCY: Substance Abuse and Mental 

Health Services Administration, HHS. 

ACTION: Notice. 

SUMMARY: The Department of Health and 

Human Services (HHS) notifies federal 

agencies of the laboratories and 

Instrumented Initial Testing Facilities 

(IITF) currently certified to meet the 

standards of the Mandatory Guidelines 

for Federal Workplace Drug Testing 

Programs (Mandatory Guidelines). 

A notice listing all currently HHScertified laboratories and IITFs is 

published in the Federal Register 

during the first week of each month. If 

any laboratory or IITF certification is 

suspended or revoked, the laboratory or 

IITF will be omitted from subsequent 

lists until such time as it is restored to 

full certification under the Mandatory 

Guidelines. 

If any laboratory or IITF has 

withdrawn from the HHS National 

Laboratory Certification Program (NLCP) 

during the past month, it will be listed 

at the end and will be omitted from the 

monthly listing thereafter. 

This notice is also available on the 

internet at http://www.samhsa.gov/ 

workplace. 

FOR FURTHER INFORMATION CONTACT: 

Giselle Hersh, Division of Workplace 

Programs, SAMHSA/CSAP, 5600 

Fishers Lane, Room 16N03A, Rockville, 

Maryland 20857; 240–276–2600 (voice). 

SUPPLEMENTARY INFORMATION: The 

Department of Health and Human 

Services (HHS) notifies federal agencies 

of the laboratories and Instrumented 

Initial Testing Facilities (IITF) currently 

certified to meet the standards of the 

Mandatory Guidelines for Federal 

Workplace Drug Testing Programs 

(Mandatory Guidelines). The Mandatory 

Guidelines were first published in the 

Federal Register on April 11, 1988 (53 

FR 11970), and subsequently revised in 

the Federal Register on June 9, 1994 (59 

FR 29908); September 30, 1997 (62 FR 

51118); April 13, 2004 (69 FR 19644); 

November 25, 2008 (73 FR 71858); 

December 10, 2008 (73 FR 75122); April 

30, 2010 (75 FR 22809); and on January 

23, 2017 (82 FR 7920). 

The Mandatory Guidelines were 

initially developed in accordance with 

Executive Order 12564 and section 503 

of Public Law 100–71. The ‘‘Mandatory 

Guidelines for Federal Workplace Drug 

Testing Programs,’’ as amended in the 

revisions listed above, requires strict 

standards that laboratories and IITFs 

must meet in order to conduct drug and 

specimen validity tests on urine 

specimens for federal agencies. 

To become certified, an applicant 

laboratory or IITF must undergo three 

rounds of performance testing plus an 

on-site inspection. To maintain that 

certification, a laboratory or IITF must 

participate in a quarterly performance 

testing program plus undergo periodic, 

on-site inspections. 

Laboratories and IITFs in the 

applicant stage of certification are not to 

be considered as meeting the minimum 

requirements described in the HHS 

Mandatory Guidelines. A HHS-certified 

laboratory or IITF must have its letter of 

certification from HHS/SAMHSA 

(formerly: HHS/NIDA), which attests 

that it has met minimum standards. 

In accordance with the Mandatory 

Guidelines dated January 23, 2017 (82 

FR 7920), the following HHS-certified 

laboratories and IITFs meet the 

minimum standards to conduct drug 

and specimen validity tests on urine 

specimens: 

HHS-Certified Instrumented Initial 

Testing Facilities 

Dynacare, 6628 50th Street NW, 

Edmonton, AB Canada T6B 2N7, 780– 

784–1190 (Formerly: GammaDynacare Medical Laboratories). 

HHS-Certified Laboratories 

ACM Medical Laboratory, Inc., 160 

Elmgrove Park, Rochester, NY 14624, 

844–486–9226. 

Alere Toxicology Services, 1111 Newton 

St., Gretna, LA 70053, 504–361–8989/ 

800–433–3823 (Formerly: Kroll 

Laboratory Specialists, Inc., 

Laboratory Specialists, Inc.). 


daltland on DSKBBV9HB2PROD with NOTICES